333 related articles for article (PubMed ID: 31735124)
1. miRNAs in gastrointestinal diseases: can we effectively deliver RNA-based therapeutics orally?
Hossian AKMN; Mackenzie GG; Mattheolabakis G
Nanomedicine (Lond); 2019 Nov; 14(21):2873-2889. PubMed ID: 31735124
[TBL] [Abstract][Full Text] [Related]
2. siRNA Targeting and Treatment of Gastrointestinal Diseases.
Chevalier R
Clin Transl Sci; 2019 Nov; 12(6):573-585. PubMed ID: 31309709
[TBL] [Abstract][Full Text] [Related]
3. Non-viral based miR delivery and recent developments.
Labatut AE; Mattheolabakis G
Eur J Pharm Biopharm; 2018 Jul; 128():82-90. PubMed ID: 29679644
[TBL] [Abstract][Full Text] [Related]
4. Polyethylenimines for siRNA and miRNA delivery in vivo.
Höbel S; Aigner A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):484-501. PubMed ID: 23720168
[TBL] [Abstract][Full Text] [Related]
5. Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology.
Chistiakov DA; Sobenin IA; Orekhov AN
Drug Deliv; 2012 Nov; 19(8):392-405. PubMed ID: 23173580
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA delivery through nanoparticles.
Lee SWL; Paoletti C; Campisi M; Osaki T; Adriani G; Kamm RD; Mattu C; Chiono V
J Control Release; 2019 Nov; 313():80-95. PubMed ID: 31622695
[TBL] [Abstract][Full Text] [Related]
7. Novel expression vectors enabling induction of gene expression by small-interfering RNAs and microRNAs.
Harel L; Gefen N; Carmi O; Orbach P; Einat P; Abitbol G
PLoS One; 2014; 9(12):e115327. PubMed ID: 25514749
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.
Maheshwari R; Tekade M; Gondaliya P; Kalia K; D'Emanuele A; Tekade RK
Nanomedicine (Lond); 2017 Nov; 12(21):2653-2675. PubMed ID: 28960165
[TBL] [Abstract][Full Text] [Related]
9. Short interfering RNA therapeutics: nanocarriers, prospects and limitations.
Mehrotra N; Tripathi RM
IET Nanobiotechnol; 2015 Dec; 9(6):386-95. PubMed ID: 26647816
[TBL] [Abstract][Full Text] [Related]
10. What's Next for Gastrointestinal Disorders: No Needles?
Urbanska AM; Karagiannis ED; Au AS; Dai SY; Mozafari M; Prakash S
J Control Release; 2016 Jan; 221():48-61. PubMed ID: 26646543
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA: Promising Roles in Cancer Therapy.
Hashemi A; Gorji-Bahri G
Curr Pharm Biotechnol; 2020; 21(12):1186-1203. PubMed ID: 32310047
[TBL] [Abstract][Full Text] [Related]
12. Oral nucleic acid therapy using multicompartmental delivery systems.
Attarwala H; Han M; Kim J; Amiji M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Mar; 10(2):. PubMed ID: 28544521
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional Poly(L-lactide)-Polyethylene Glycol-Grafted Graphene Quantum Dots for Intracellular MicroRNA Imaging and Combined Specific-Gene-Targeting Agents Delivery for Improved Therapeutics.
Dong H; Dai W; Ju H; Lu H; Wang S; Xu L; Zhou SF; Zhang Y; Zhang X
ACS Appl Mater Interfaces; 2015 May; 7(20):11015-23. PubMed ID: 25942410
[TBL] [Abstract][Full Text] [Related]
14. Role of microRNAs in gastrointestinal smooth muscle fibrosis and dysfunction: novel molecular perspectives on the pathophysiology and therapeutic targeting.
Krishna CV; Singh J; Thangavel C; Rattan S
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G449-59. PubMed ID: 26822916
[TBL] [Abstract][Full Text] [Related]
15. Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract.
Kriegel C; Attarwala H; Amiji M
Adv Drug Deliv Rev; 2013 Jun; 65(6):891-901. PubMed ID: 23220324
[TBL] [Abstract][Full Text] [Related]
16. Photoluminescent and biodegradable polycitrate-polyethylene glycol-polyethyleneimine polymers as highly biocompatible and efficient vectors for bioimaging-guided siRNA and miRNA delivery.
Wang M; Guo Y; Yu M; Ma PX; Mao C; Lei B
Acta Biomater; 2017 May; 54():69-80. PubMed ID: 28219808
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.
Kwekkeboom RF; Lei Z; Doevendans PA; Musters RJ; Sluijter JP
Clin Sci (Lond); 2014 Sep; 127(6):351-65. PubMed ID: 24895056
[TBL] [Abstract][Full Text] [Related]
18. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
[TBL] [Abstract][Full Text] [Related]
19. Design, preparation and application of nucleic acid delivery carriers.
Yang J; Liu H; Zhang X
Biotechnol Adv; 2014; 32(4):804-17. PubMed ID: 24239630
[TBL] [Abstract][Full Text] [Related]
20. siRNA therapeutics: a clinical reality.
Saw PE; Song EW
Sci China Life Sci; 2020 Apr; 63(4):485-500. PubMed ID: 31054052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
